Metabolic outcome during 1 year in newly detected hypertensives

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1985 • 29,733 citations

Global and societal implications of the diabetes epidemic

2001 • 5,825 citations

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2002 • 5,558 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 5,471 citations

Blood pressure, stroke, and coronary heart disease

1990 • 4,424 citations

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

1987 • 3,889 citations

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

1999 • 3,464 citations

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 • 2,051 citations

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 1,592 citations

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 • 1,472 citations

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

2001 • 1,240 citations

Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1998 • 1,120 citations

Hypertriglyceridemia as a Cardiovascular Risk Factor

1998 • 1,074 citations

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

2003 • 466 citations

Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy

2002 • 455 citations

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

2002 • 403 citations

Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

1991 • 345 citations

Apolipoproteins and ischaemic heart disease: implications for screening

1994 • 247 citations

Atherogenicity of Triglyceride-Rich Lipoproteins

1998 • 229 citations

Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes

2001 • 134 citations

Incubation period of coronary heart disease.

1982 • 107 citations

Antihypertensive therapy and lipids: Paradoxical influences on cardiovascular disease risk

1986 • 91 citations

Metabolic manifestations of low-dose diuretics

1996 • 69 citations

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study

1996 • 51 citations

Glucose and cholesterol elevations during thiazide therapy: Intention-to-treat versus actual on-therapy experience

1995 • 28 citations

Antihypertensive Treatment with Candesartan Cilexetil does not Affect Glucose Homeostasis or Serum Lipid Profile in Patients with Mild Hypertension and Type II Diabetes

1998 • 24 citations

Clinical review 43: Treatment of hypertension: focus on prevention of coronary heart disease

1993 • 10 citations

Effects on Plasma Lipids during Long Term Antihypertensive Treatment with Felodipine

1992 • 5 citations